
Pharmaceutical Updates
22 May 2026
Eli Lilly’s triple agonist retatrutide shows 28% weight-loss in key Phase-3 study
Read MoreFollow Docthub for opportunities, insights, and the people driving healthcare forward.
Latest News
View moreExplore by Category
Exam Dates & Updates
View moreHealthcare Business
View moreExplore by
Disease Insights
View moreExplore by Stream
Medical Academia
View moreExplore by Specialty
Milestone
View morePharmaceutical Updates
View moreHealth Technology
View moreHealth Policy
View moreAdmissions Open
View moreIn Conversation
View moreJoining Announcement
View moreDigital Health
View moreEvent Announcement
View moreHealth Day Celebration
View morePatient Success Stories
View more